Vivtex Corporation is a biotechnology company transforming the oral delivery of therapeutics. The company is developing a robotics-driven platform that integrates its proprietary GI-ORIS™ high-throughput screening system — a “GI tract on a chip” — with AI-enabled computational modeling to design and optimize orally delivered therapeutics, including biologics, for predictable human performance.